Skip to main content

Michael Brown

Assistant Professor in Neurosurgery
Neurosurgery, Neuro-Oncology

Selected Grants


Epigenetic Programming of T Cells for Enhanced Cellular Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)

ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2028

ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas

ResearchInvestigator · Awarded by National Institutes of Health · 2022 - 2027

Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Beyond tumor staging: measuring immune status at initial diagnosis to detect and prevent melanoma recurrence

ResearchInvestigator · Awarded by Department of Defense · 2023 - 2026

Epigenetic Programming of T Cells for Enhanced Cellular Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029

Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)

ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2028

ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas

ResearchInvestigator · Awarded by National Institutes of Health · 2022 - 2027

Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027

Beyond tumor staging: measuring immune status at initial diagnosis to detect and prevent melanoma recurrence

ResearchInvestigator · Awarded by Department of Defense · 2023 - 2026

Reviving cancer immune surveillance with CD4 T cell help

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025

Reviving cancer immune surveillance with CD4 T cell help

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2023

Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?

ResearchCollaborator · Awarded by National Institutes of Health · 2019 - 2022

Cancer Immunotherapy Through Intratumoral Activation of Recall Responses

FellowshipPI-Fellow · Awarded by National Institutes of Health · 2018 - 2021

Cancer Immunotherapy Through Intratumoral Activation of Recall Responses

FellowshipPI-Fellow · Awarded by National Cancer Center · 2017 - 2019

Oncolytic Virotherapy of Meningeal Cancer

ResearchResearch Assistant · Awarded by National Institutes of Health · 2009 - 2015

External Relationships


  • Istari Oncology
  • Menarini Ricerche S.p.A.

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.